Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry Set for Steady Growth at 3.6% CAGR, Reaching US$47 Billion by 2034 | FMI
The Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry is projected to reach a staggering US$47.04 billion by 2034, reflecting a steady growth trajectory. According [read full press release…]
